Browsing by Subject "Gonadorelin agonist"
Now showing items 1-2 of 2
(2010)Cancer of unknown primary (CUP) is a common, well-recognized and heterogeneous clinical syndrome. Patients with CUP present with metastatic disease in the absence of an identifiable primary tumour despite a diagnostic ...
Levels of absolute survival benefit for systemic therapies of advanced cancer: A call for standards (2003)Research on systemic interventions in patients with advanced stage malignancies should be systematised with an emphasis on the absolute gain in survival for the median patient. Such information is most meaningful with ...